Celldex Therapeutics – Recurrent GBM

Access Program Information

Celldex endeavors to make investigational products available to patients with
life-threatening diseases who have exhausted other treatment options and where there is a
reasonable expectation of benefit over risk. Requests for expanded access to rindopepimut in
patients with EGFRvlll expressing recurrent glioblastoma will be considered.

Rare Disease: